{"id":"W2804564619","doi":"10.1016/j.bpg.2018.05.003","title":"Biosimilars in ulcerative colitis: When and for who?","year":2018,"lang":"en","type":"review","venue":"Best Practice & Research Clinical Gastroenterology","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":8,"is_retracted":false,"has_abstract":false,"ca_institutions":"McGill University","funders":"American Gastroenterological Association; Dr. Falk Pharma; Pfizer; Amgen","keywords":"Biosimilar; Infliximab; Medicine; Ulcerative colitis; Clinical trial; Interchangeability; Intensive care medicine; Pharmacology; Internal medicine; Disease","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","metaepi_narrow","sts","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.02027633,0.0005953521,0.003298618,0.0005830922,0.0002830042,0.0001066831,0.0008911892,0.002365625,0.0003687211],"category_scores_gemma":[0.02566732,0.0004621181,0.0006426473,0.0003257918,0.004097747,0.0002297725,0.0009781329,0.004363903,0.0002550592],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001474243,"about_ca_system_score_gemma":0.0004870686,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00005885852,"about_ca_topic_score_gemma":0.0006466594,"domain_scores_codex":[0.974558,0.01960975,0.00220329,0.001680813,0.0001581026,0.001790069],"domain_scores_gemma":[0.9742506,0.02329697,0.0006796205,0.0007807811,0.0007730876,0.0002189862],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.007165822,0.002637742,0.0005268807,0.003316566,0.001854428,0.0001249619,0.000100781,8.578644e-9,0.000001742851,0.001104572,0.1209786,0.8621879],"study_design_scores_gemma":[0.002144407,0.01106807,0.00009405808,0.002946139,0.0007917035,0.0003563093,0.0001520838,0.000002480763,0.00000106778,0.0006800729,0.9815149,0.0002486974],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00006145347,0.9890015,0.0002789642,0.005219925,0.001020044,0.003024652,0.0004095088,0.00002997922,0.0009539411],"genre_scores_gemma":[0.0000105961,0.9900646,0.004781347,0.001976586,0.0004320415,0.0006085321,0.00010286,0.00007247359,0.001950913],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.8619393,"threshold_uncertainty_score":0.999783,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.3338195466782778,"score_gpt":0.5656493369924445,"score_spread":0.2318297903141666,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}